Pharmacists in Canajoharie, NY Accepting Medicare
2 Pharmacists found. Showing 1 - 2
 Dr. Laura Voght Pietromonaco, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26 Church St, Canajoharie, NY 13317 Phone: 518-673-8086 Fax: 518-673-5112 |
 David W Voght Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26 Church St, Canajoharie, NY 13317 Phone: 518-673-8086 Fax: 518-673-5112 |
News Archive
Today's Op-Eds: Congress needs conservative leadership; reviving tort reform; can states afford to drop Medicaid?
Nothing has gone quite so awry as the massive, government-run Obama health program, and it is plain that the individual mandate, the employee mandate, the abortion funding, the tangle of outsider/insider councils like the comparative effectiveness board and the effective nationalization of healthcare under grants of authority to the Department of Health and Human Services.
New research shows mercury levels are higher in some tuna species
New research showing that that mercury levels are higher in some species of tuna could help consumers minimize their consumption of the silvery metal in their sushi and provide a powerful new tool for regulatory organizations.
Guinea worm disease on verge of eradication, WHO reports
"The World Health Organization reports Guinea worm disease, which has plagued people for thousands of years, is on the verge of eradication," VOA News reports. "The U.N. agency says fewer than 400 cases of the infectious parasitic disease exist in four African countries, and that it will soon become only the second, after smallpox, to be wiped off the face of the earth," the news service writes.
Retrovirox receives another NIH grant for novel inhibitors of HIV entry
RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.
› Verified 7 days ago